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Background: Herpes simplex virus 1 (HSV-1) and varicella zoster virus (VZV) cause extensive intra-ocular and neural
infections in humans and are closely related to Felid herpes virus 1 (FeHV-1). We report the extent of intra-ocular
replication and the extent and morphological aspects of neural replication during the acute and latent phases of
FeHV-1 infection. Juvenile, SPF cats were inoculated with FeHV-1. Additional cats were used as negative controls.
Cats were euthanized on days 6, 10, and 30 post-inoculation.
Results: FeHV-1 was isolated from the conjunctiva, cornea, uveal tract, retina, optic nerve, ciliary ganglion (CG),
pterygopalatine ganglion (PTPG), trigeminal ganglion (TG), brainstem, visual cortex, cerebellum, and olfactory bulb
of infected cats during the acute phase, but not the cranial cervical ganglion (CCG) and optic chiasm. Viral DNA
was detected in all tissues during acute infection by a real-time quantitative PCR assay. On day 30, viral DNA was
detected in all TG, all CCG, and 2 PTPG. Histologically mild inflammation and ganglion cell loss were noted within
the TG during acute, but not latent infection. Using linear regression, a strong correlation existed between clinical
score and day 30 viral DNA copy number within the TG.
Conclusions: The correlation between clinical score and day 30 viral DNA copy number suggests the severity of
the acute clinical infection is related to the quantity of latent viral DNA. The histologic response was similar to that
seen during HSV-1 or VZV infection. To the author’s knowledge this is the first report of FeHV-1 infection involving
intraocular structures and autonomic ganglia.
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Felid herpesvirus-1 (FeHV-1) is an enveloped dsDNA
virus classified under the genus Varicellovirus within the
subfamily Alphaherpesvirinae [1]. In susceptible cats,
FeHV-1 accounts for approximately 50-75% of upper
respiratory infections [2]. Following exposure of the con-
junctival and oronasal mucous membranes, FeHV-1 rep-
licates extensively at these sites, resulting in pyrexia,
depression, anorexia, sneezing, conjunctivitis, keratitis,
and oculonasal discharge [3]. The acute phase of FeHV-* Correspondence: townsenw@purdue.edu
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distribution, and reproduction in any medium1 infection is followed by lifelong latency [4]. Latency is
defined as an asymptomatic period during which infec-
tious virus cannot be recovered from tissues, but can be
induced to reactivate through organ culture or explant-
ation [5,6]. Reactivation of a previously latent infection
occurs readily in response to natural stressors or admin-
istration of corticosteroids [4]. Reactivation is associated
with renewed virus production, shedding of infectious
virus, and ocular or nasal lesions [4].
In a murine herpes simplex virus 1 (HSV-1) model, the
spread of HSV-1 from initial corneal epithelial replication
sites to intra-ocular structures and the nervous system has
been well documented [7]. After topical inoculation of
scarified corneas of adult mice, viral antigen has been
detected using immunohistochemistry by day 6 in the cor-
nea, conjunctiva, iris, choroid, retina, ciliary ganglia (CG),
trigeminal ganglia (TG), pterygopalatine ganglia (PTPG),tral Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/2.0), which permits unrestricted use,
, provided the original work is properly cited.
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hypothalamus [7]. HSV-1 infection has also been docu-
mented in human CG [8]. Latent varicella zoster virus
(VZV) has been demonstrated in cranial nerve ganglia,
dorsal root ganglia, and autonomic nervous system gan-
glia of human cadavers using polymerase chain reaction
(PCR) and in situ hybridization [9-12]. The VZV has also
been isolated from corneas of humans with acquired
immunodeficiency syndrome and chronic keratitis [13].
Previous reports have shown that FeHV-1 can be isolated
during the acute phase of the disease from the cornea,
conjunctiva, nasal epithelium, nasal turbinates, tonsils,
and TG [14,15]. The presence of viral DNA during latency
has been demonstrated by PCR in the cornea, nasal
turbinates, olfactory bulbs, cerebrum, optic nerve, optic
chiasm, and TG [16-18]. Latency associated transcripts
(LATs), small strands of RNA transcribed by the virus
within latently infected neurons [5,6], have been shown to
be present within latently infected TG [18].
The TG or other neural tissues of FeHV-1 infected an-
imals have not been examined histologically to docu-
ment the lesions caused by FeHV-1 infection. In the TG
of mice acutely infected with HSV-1, the virus has been
detected within both neural and non-neural cells [19].
Infection with HSV-1 also induced apoptosis of neurons
and a histiocytic and lymphocytic infiltrate [20-22]. The
TG of mice latently infected with HSV-1 typically dem-
onstrated a mononuclear cellular infiltrate that has also
been documented in the TG of latently infected humans
[23-28]. This cellular infiltrate is believed to play a crit-
ical role in the prevention of recrudescence [29].
In this study we defined the ocular and neural tissues
with detectable virus during active and latent FeHV-1 in-
fection and quantified the amount of virus present within
the cornea, conjunctiva, TG, CG, PTPG, cranial cervical
ganglia (CCG), uvea, retina, optic nerve, optic chiasm, vis-
ual cortex, cerebellum, brainstem, and olfactory bulb. The
study population consisted of 3 groups each composed of
4 inoculated cats and 1 control cat. Samples were col-
lected from group 1 on day 6 post inoculation (PI) when
all FeHV-1 exposed cats were exhibiting ocular signs,
from group 2 on day 10 PI which was the peak of ocular
and respiratory signs, and from group 3 on day 30 PI
when the clinical signs had resolved and latency was
established. The TG and CG were examined histologically
to detect lesions associated with both active and latent in-
fection. Correlations between the severity of clinical signs
and the viral load within the TG were made from samples
collected on days 6, 10, and 30 post-inoculation.
Results
Clinical scores and serologic evaluation
All inoculated cats developed clinical signs such as sneez-
ing, ocular discharge, nasal discharge, anorexia, andelevated body temperature that were consistent with
FeHV-1 infection, whereas all control cats remained
disease-free. The median total of the clinical scores from
day 0 to the day of euthanasia was 6 (range 4 to 8) for
group 1 (day 6 PI), 21 (range 17 to 28) for group 2 (day 10
PI), and 19.5 (range 17 to 32) for group 3 (day 30 PI). In
group 3 all clinical signs had resolved prior to euthanasia.
The control cats did not develop FeHV-1 specific virus
neutralizing (VN) antibodies. The group 3 inoculated cats
seroconverted as the FeHV-1 VN antibody titers were less
than 1:4 at days 7 and 14 PI and increased to 1:32 to 1:128
at days 21 and 30 PI.
Virus isolation (VI)
The VI data are presented in Table 1. FeHV-1 was not
isolated from any of the samples taken from the control
cats. Except for the cranial cervical ganglion, virus was
isolated from each of the tissue types collected from
group 1 (day 6 PI), group 2 (day 10 PI), or both. Except
for a single corneal sample from a cat in group 3 (cat
#11), virus was not isolated from any tissue sample col-
lected from group 3 (day 30 PI).
RT-PCR
The PCR results for each individual tissue type and the
FeHV-1 DNA copy numbers reported per 100 cells of
the homogenized tissues examined are shown in Table 2
and Figure 1. As the number of FeHV-1 genomes/μg of
sample DNA was known, the FeHV-1 copy number per
100 cells was calculated based on 260,000 haploid gen-
ome equivalents/μg of feline cellular DNA [30]. Individ-
ual cell types were not examined. The FeHV-1 copy
number per 100 cells was reported to standardize com-
parisons between the various tissues as different tissues
yielded different amounts of DNA. FeHV-1 DNA was
not detected by real-time PCR in any of the samples
obtained from the control cats. For each group, the total
of the clinical scores from Day 0 to the day of euthanasia
and the FeHV-1 DNA copy number per 100 cells in the
TG were compared by linear regression (Figure 2). The
total clinical score and FeHV-1 copy number were
strongly correlated (p=0.021, R2=0.9583) for group 3.
The clinical score and FeHV-1 copy number were not
correlated for groups 1 (p=0.39, R2=0.37) or 2 (p=0.41,
R2=0.36).
Histopathology
The corneas, conjunctiva, TG, and CG were examined
histologically. No histological changes were found within
the cornea, conjunctiva, TG, or CG of control animals.
No histologic changes were noted within any of the
corneal samples except for one cat from group 2. In that
sample multiple, solitary, degenerate epithelial cells and
a mild lymphocytic infiltrate were noted. Histologic













Cornea 4/4 4/4 1/4
Conjunctiva 4/4 4/4 0/4
Trigeminal ganglia 2/4 2/4 0/4
Ciliary ganglia 2/4 2/4 0/4
PTPG 4/4 3/4 0/4
CCG 0/4 0/4 0/4
Uvea 4/4 4/4 0/4
Retina 4/4 4/4 0/4
Optic nerve 3/4 1/4 0/4
Optic chiasm 3/4 0/4 0/4
Visual cortex 4/4 1/4 0/4
Cerebellum 3/4 3/4 0/4
Brainstem 3/4 2/4 0/4
Olfactory bulb 4/4 2/4 0/4
Virus isolation results obtained for each tissue type on each day. All control
samples were negative and are not listed within this table. PTPG
pterygopalatine ganglia. CCG cranial cervical ganglia.
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loss and lymphoplasmacytic inflammation were seen in
the conjunctival samples from all 12 inoculated cats.
The changes were milder in the group 3 cats. All 4/4
TG obtained from group 1 and 3/4 obtained from groupTable 2 Real time PCR assay results
Group 1 (Day 6) Group 2
Tissue RT-PCR Average FeHV-1 DNA
copies/100 cells
RT-PCR
(#pos/# tested) (#pos/# t
Cornea 4/4 3915 4/4
Conjunctiva 4/4 6950 4/4
TG 4/4 106 4/4
CG 4/4 65 4/4
PTPG 4/4 410 4/4
CCG 3/4 1 4/4
Uvea 4/4 533 4/4
Retina 4/4 2 4/4
Optic nerve 4/4 35 4/4
Op chiasm 4/4 <1 4/4
Vis cortex 4/4 <1 2/4
Cerebellum 4/4 1 4/4
Brainstem 3/4 3 2/4
Olf bulb 4/4 9 4/4
Real-time PCR assay (RT-PCR) results obtained for each tissue type on each day. All
trigeminal ganglia. CG ciliary ganglia. PTPG pterygopalatine ganglia. CCG cranial cer
olfactory bulb.2 had histologic changes consisting of ganglion cell death,
depletion of ganglionic cells, increased numbers of glial
cells, and lymphoplasmacytic inflammation (Figure 3).
One/four TG obtained from group 3 showed ganglion cell
depletion, but no concurrent inflammation. Histologic
changes were not evident in the examined CG of inocu-
lated cats. However in 3 cats the small size of the CG
precluded obtaining an appropriate section for histologic
evaluation.
Discussion
FeHV-1 infection in cats is a valid natural host model to
study herpesvirus-induced ocular disease and latency in
humans. In this study we describe intra-ocular and
neural FeHV-1 involvement during the acute phase of
the infection of tissues (CG, PTPG, CCG, uvea, and ret-
ina) from which FeHV-1 has not previously been iso-
lated [14-18]. During the latent phase of infection, latent
viral DNA was detected not only within the TG, but also
the CCG of all cats and in PTPG of two of the inocu-
lated cats. Morphologically ganglionic cell death and in-
flammation were present within the TG during the acute
phase of infection.
To our knowledge, involvement of the uveal tract dur-
ing the acute phase of FeHV-1 infection has not previ-
ously been documented. Felid herpesvirus-1 DNA has
been detected by PCR in the aqueous humor of cats with
idiopathic uveitis and in clinically normal cats [31].
However, in previous studies only the uveal tract of la-
tently infected cats has been examined and virus was(Day 10) Group 3 (Day 30)
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Figure 1 FeHV-1 copy number versus days post inoculation.
The average number of copies of FeHV-1 genome per 100 cells was
plotted against the days post inoculation. The FeHV-1 copy number
decreases over time in most tissues sampled. However, the ciliary
ganglia, trigeminal ganglia, cranial cervical ganglia, and optic chiasm
had higher levels of virus present at day 10 than at day 6.
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uveal tract demonstrates that cats, like mice infected
with HSV-1 [32], experience active intra-ocular virus
replication.
Another not previously reported finding was the isola-
tion of FeHV-1 from all retinas during the acute phase
of the disease. As retinal homogenates were used in the
current study, we were unable to determine the specific
layer of the retina involved during the acute phase of in-
fection. In one murine model HSV-1 study, utilizing
corneal scarification prior to inoculation, infectious viruswas detected within the retinal photoreceptors [33]. Note-
worthy also is that after intracameral administration of
HSV-1 in a murine HSV-1 model, the virus is detected
within the contralateral, but not the ipsilateral retina [34].
In the present study, FeHV-1 reached the retina without
intracameral injection or corneal scarification. No visual
deficits were noted. However fundic examinations were
not performed as part of this study and therefore retinal
abnormalities might not have been detected. In addition,
histologic examination was not performed on any of the
intra-ocular tissues. Therefore while FeHV-1 was detected
within multiple ocular tissues, the morphological changes
due to the presence of the virus were not evaluated.
In the murine HSV-1 model an intense inflammatory
response is noted histologically in response to the intra-
ocular infection [33,34]. In contrast, the cats in this
study showed no clinical signs of intraocular inflamma-
tion despite the presence of relatively large amounts of
replicating virus. Perhaps the magnitude of the infection
(8–14 times less virus in the intra-ocular tissues com-
pared with the cornea and conjunctiva) explains the lack
of intra-ocular inflammation noted in this study. The
amount of FeHV-1 present within the intra-ocular tissues
is much less than the 2×104 plaque forming units used to
inoculate the anterior chamber in the murine model [34].
Ocular examination with a slit-lamp biomicroscope would
be required in future studies to detect subtle inflamma-
tion. Future studies combining histologic examination and
in situ hybridization will further clarify this difference.
Virus particles and FeHV-1 DNA were detected during
this study within the optic nerve and optic chiasm. Since
these tissues lack neuronal cell bodies [35] the virus
must either have been undergoing axonal transport [35],
have infected glial cells within the optic nerve and chi-
asm [36], or have been present within leukocytes within
the neural tissues [37]. Reubel et al. [16] and Weigler
et al. [17] have previously detected latent FeHV-1 DNA
within the optic nerves and chiasms using PCR assays.
In this study latent viral DNA was not detected within
optic chiasm homogenates. Viral FeHV-1 DNA, but not
infectious virus, was present in the optic nerve of one
cat. However in this cat virus was isolated from the cor-
nea making it difficult to conclude that the DNA present
in the optic nerve was latent.
FeHV-1 was also detected within the ciliary, ptery-
gopalatine, and cranial cervical autonomic ganglia ex-
amined in this study. Involvement of the autonomic
ganglia has not previously been associated with FeHV-1
infection. In this study FeHV-1 established latent infec-
tions within the CCG of all cats. The consistent pres-
ence of latent FeHV-1 within the CCG is similar to the
behavior of varicella zoster virus (VZV), also a member
of the Varicellovirus genus, which is consistently found
















Total Clinical Score for Group 3 from day 0 to day of euthanasia
Figure 2 Clinical score versus FeHV-1 copy number within the trigeminal ganglia (TG). Linear regression of the total clinical score for
group 3 from day 0 to the day of euthanasia compared to the FeHV-1 copy number per 100 cells within the TG. A close linear relationship was
seen between the amount of latent virus present within the TG and the total clinical score for each individual animal in group 3. The p-value was
0.021 and R2 was 0.9583.
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tency in humans is restricted to cranial nerve ganglia
[38,39]. Infection of the autonomic ganglia provides ex-
tensive neural connection from the nasal passages and
oropharynx to the ocular surface and intra-ocular struc-
tures [40]. These neural pathways have been well de-
scribed by Labetoulle [32]. Latency within the autonomic
ganglia as well as the TG may results in herpetic ocular
disease which could involve not only the cornea, but also
the uveal tract and retina [41].
Histologically the CG examined all appeared normal.
Therefore either inflammatory changes do not occur in
the CG or they were very focal and missed on histo-
logical sectioning. In contrast, all of the TG collected at
days 6 and 10 PI showed ganglionic cell death, depletion
of ganglion cells, increased numbers of glial cells, and
lymphoplasmacytic inflammation. In human patients
with HSV-1 infection histologic examination of the gan-
glia has not been performed during active infection dueFigure 3 Histologic section of the trigeminal ganglion.
Hematoxylin and eosin stained section of the trigeminal ganglion
taken at 400X magnification. Note the lymphoplasmacytic
inflammation surrounding the neurons.to the obvious difficulty in obtaining tissue samples [42].
However in the murine model of HSV-1 infection, apop-
tosis of neurons and histiocytic and lymphocytic infil-
trates have been noted [20-22]. In humans infected with
VZV, neuritis and degeneration of sensory nerve roots
have been noted [43,44]. In this study, only one section
of TG from group 3 showed histologic changes: a loss of
ganglion cells, but no concurrent inflammation. This
was an unexpected finding as mice latently infected with
HSV-1 typically demonstrate a mononuclear cellular in-
filtrate [23-27]. In human TG, latent HSV-1 infection
has also been associated with chronic inflammation. A
lymphocytic infiltrate has also been noted in bovine TG
latently infected with bovine herpesvirus −1 (BHV-1)
[45]. Interestingly in one study, lymphocytes consist-
ently surrounded latently infected HSV-1 human TG
neurons, but not the VZV-positive neurons [28]. Latent
FeHV-1 infection may be more similar to latent VZV in
this aspect.
In the current study, the FeHV-1 copy numbers in the
TG were much higher than those previously reported
[30]. This may be due to the fact that the time frame of
this study was 30 days versus 56 days in the previous
study. This may also be due to differences in the viru-
lence of the viral strains used in each study, C-27 versus
SGE [30]. The strain of HSV-1 has been shown to influ-
ence the number of latent virus particles within individ-
ual neurons in a murine model [46]. The amount of
virus inoculated was higher in the previous study of
FeHV-1 [30] than this study and therefore was unlikely
to play a role in the increased copy numbers within the
TG. Based on studies of HSV-1, latency is typically
established in only a small percentage of sensory neu-
rons in humans [47] and the copy number is usually
only 2–50 copies/cell [47,48]. The copy numbers are re-
portedly similar for VZV [49,50]. Interestingly in our
study wide variation was seen in the amount of latent
FeHV-1 DNA detected despite all individuals receiving
Table 3 Clinical scoring system
Clinical sign Daily score if present
Fever
103.0 to 103.9°F 1







Open mouth breathing 3
Anorexia 1
Dehydration 1
Hypothermia < 99°F 2
Oral ulcers (lingual or oral mucosa)
1 ulcer <4 mm 1
Multiple ulcers <4 mm 3
Ulcer or ulcers >4 mm 5
Salivating 1
External ulcers (lip or nares)
Non-bleeding ulcer 4
Bleeding ulcer 6
The following scoring system was modified from the published USDA Scoring
Method for FeHV-1 [56] and was used to assign daily clinical scores for each
cat. The highest possible score for a cat on any given day was 31.
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of HSV-1, the number of viral genomes was directly pro-
portional to the titer of infectious inoculum [51]. How-
ever in a different rabbit model and also murine model,
this did not hold true [52,53]. In the study reported here
the latent viral load was strongly associated with the se-
verity of clinical signs as denoted by the total clinical
score from day 0 to the day of euthanasia. For mice
infected with HSV-1, a higher latency load is associated
with an increased risk of recurrence [54]. In human pa-
tients with HSV-1 and HSV-2 infection, the severity of
the first episode and the latency load are strongly linked
to the recurrence rate [55]. This data would imply that
animals with more severe clinical signs were at higher
risk for recrudescence.
Conclusions
The intra-ocular and neural involvement during FeHV-1
infection was more widespread than previously known.
Autonomic ganglia as well as sensory ganglia harbored
latent FeHV-1. The histologic response in neural tissue
was similar to that seen during HSV-1 or VZV infection.
Finally increased severity of clinical signs was associated




All experiments were performed in full compliance with
the ARVO Statement for the Use of Animals in Oph-
thalmic and Vision Research and with approval from the
Michigan State University Animal Care and Use Com-
mittee. A total of fifteen 6-month-old female specific
pathogen free (SPF) cats were obtained from a commer-
cial vendor (Liberty Research, Inc, Waverly, NY). Cats
were housed in individual cages with the infected and
control groups in separate containment rooms (Biocon-
tainment Level-2) with controlled temperature, humid-
ity, and lighting. All personnel wore sterile disposable
Tyvek coveralls, gloves, head covers, and shoes covers
upon entering a containment room. Cats were fed a
combination of dry and moist diets. All cats were accli-
mated for 7 days before virus exposure.
Inoculation and clinical scores
Cats were anesthetized via chamber administration of
halothane and oxygen. Twelve cats were infected by in-
stilling 1.05 ml (1×105 TCID50/ml) of the C-27 strain of
FeHV-1 (ATCC, Manassas, VA) into the left and right
conjunctival sacs (350 μl each), external nares (150 μl
each), and oropharynx (50 μl). The other 3 cats served
as controls. Animals were observed and clinical scores
assigned daily to each cat by one of two trained ob-
servers after at least 15 minutes of observation using ascoring system modified from the USDA Supplemental
Assay Method 311 (Table 3) [56].
Serologic examination
All cats were determined to be serologically negative for
FeHV-1 virus neutralizing antibodies prior to inoculation.
Blood samples were collected for evaluation of FeHV-1
VN antibodies using a modified microtiter neutralization
assay [57,58] on days 7, 14, and 21 post-inoculation from
the cats euthanized on day 30 (group 3).
Sample collection
Groups of 4 inoculated cats and 1 control cat were eu-
thanized with an intravenous injection of pentobarbital
sodium on day 6 PI when all FeHV-1 exposed cats were
exhibiting ocular signs (group 1), on day 10 PI corre-
sponding to peak ocular and respiratory signs (group 2),
and on day 30 PI when the clinical signs had resolved
and latency was established (group 3). Using sterile tech-
nique the entire right conjunctiva, cornea, uveal tract,
retina, optic nerve, entire optic chiasm, CG, PTPG,
CCG, TG, brainstem, visual cortex, cerebellum, and ol-
factory bulb were placed in individual Eppendorf tubes
and frozen at –80°C. Gloves were changed and the
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tion site. To each Eppendorf tube, 800 μl of Bovarnick’s
solution and sterile homogenizing beads were added.
The Eppendorf tube was then placed in the mixer mill
(MM300, Qiagen, Valencia, CA) for tissue disruption
and homogenization. The resulting homogenate was fro-
zen at –80°C. Sections of the contralateral cornea and
conjunctiva and the entire contralateral TG and CG
were collected for histological evaluation.Virus isolation
A 200 μl aliquot of each tissue’s homogenate was re-
served for DNA extraction. The remaining suspension
was brought to 3 ml with Eagle’s Minimum Essential
Medium (EMEM), supplemented with 10% fetal bovine
serum. From the homogenate, 500 μl aliquots of filtered
(0.45 μm) tissue extracts were inoculated onto monolayers
of Crandell Reese feline kidney (CRFK) cells grown onto
24-well plates. The inoculated cells were examined daily
for the appearance of characteristic cytopathic effects. Viral
isolates were verified to be FeHV-1 by direct immunofluor-
escence (application of direct polyclonal FeHV-1 fluores-
cent antibody) (American BioResearch, Pullman, WA).
Virus isolation attempts were performed in duplicate.SYBR green-based real-time quantitative PCR
DNA extraction was performed utilizing the Qiagen
DNEasy Blood and Tissue kit (Qiagen, Valencia, CA).
DNA quantitation was performed spectrophotometrically.
Negative extraction controls consisted of 200 μl of PBS.
The real-time quantitative SYBR Green PCR assay
targeted a 478 bp fragment containing the FeHV-1 gE
gene. The sequence of the forward primer was 5′-GGT
CAT GTG TAA TGT TGA CG-3′, and the sequence of
the reverse primer was 5′- GTC TTT GGT TCT GAT
GAG AG-3′ [56]. The sensitivity of this assay was 10
genomic copies of FeHV-1. Its dynamic range was con-
firmed by its ability to amplify the targeted DNA frag-
ment of 48 known clinical isolates of FeHV-1.
The amplification kit used was the Quantitect SYBR
Green PCR Kit (QIAGEN, Valencia, CA) with a final pri-
mer concentration of 0.5 μM. The 50 μl real time PCR re-
action mixture consisted of 25 μl 2× SYBR Green mix
(QIAGEN, Valencia, CA), 1 μl forward primer (25 pmol/μl),
1 μl reverse primer (25 pmol/μl), 100 ng of template DNA
(20 ng of template DNA for CG and pterygopalatine
ganglia) and ddH2O. Real-time PCR was performed on a
iCycler™ iQ® System (Bio-Rad Laboratories, Hercules, CA)
with the following cycling conditions: pre-denaturation at
95°C for 15 min, followed by 45 cycles of 94°C for 30 sec,
50°C for 30 sec and 72°C for 1 min. A post-amplification
melt curve analysis was incorporated in the run to con-
firm the specificity of the amplicons generated. Post-PCR analysis was performed using the iCycler detection
software version 1.1.
All reactions were conducted in duplicate. The DNA
extraction controls and PCR reagent controls were in-
cluded in each run. A standard curve of threshold cycle
in relation to viral copy number was constructed. The
standard curve for FeHV-1 was generated by a series of
10-fold dilutions (10-1 – 10-6 copies) of purified FeHV-1
stock DNA. Samples for the standard curve were assayed
in triplicate for each run and also served as the positive
control. As the number of FeHV-1 genomes/μg of gan-
glionic DNA was known, the FeHV-1 copy number per
100 cells was calculated based on 260,000 haploid gen-
ome equivalents/μg of feline cellular DNA [30].
Histopathology
Following fixation in 10% buffered formalin, the con-
junctiva, cornea, TG, and CG were paraffin-embedded,
sectioned at a thickness of 5 μm, and stained with
hematoxylin and eosin. Samples were examined by light
microscopy by a single board-certified veterinary path-
ologist (MK).
Statistical evaluation
Linear regression was performed to compare the total of
the clinical scores from Day 0 to the day of euthanasia
and the FeHV-1 copy number within the TG in groups
1, 2, and 3. Significance was set at p<0.05.
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